Confidently Navigating ADPKD: Understanding the New KDIGO Guideline

ADPKD affects more than just the kidneys. In part three of our four-part series, we’ll explore how ADPKD impacts the heart, liver, bones, and metabolic health. There will be plenty of time to get your questions answered by our experts.  

You’ll learn about: 

Heart and vascular risks in ADPKD, including brain aneurysms.

Polycystic liver disease (PLD) and how to manage symptoms.

The impact of ADPKD on bone health, metabolism, and urinary health.

Preventive care strategies for whole-body health.

Who should attend? 

Patients with ADPKD

Family members and caregivers

Those interested in kidney-friendly diets and wellness

Healthcare providers seeking patient-centered guidance

Guest Speakers: 

Craig Gordon, M.D., M.S.: Director of the PKD Foundation Center of Excellence at Tufts Medical Center is a nephrologist with expertise in hepatitis C in CKD, thrombotic microangiopathy, polycystic kidney disease, and kidney transplantation. He has held academic and leadership roles at Boston Medical Center and Tufts Medical Center, serving as a renal fellowship program director and course director for renal pathophysiology. Actively involved in clinical research and guideline development, he has contributed to multiple KDIGO guidelines and helped establish a multidisciplinary team for managing thrombotic microangiopathy.

Pranav Garimella, MBBS, MPH, FASN: Director of the PKD Foundation Center of Excellence at University of California San Diego is a board-certified nephrologist with expertise in chronic kidney disease, polycystic kidney disease, kidney stones, and metabolic bone disease. A trained epidemiologist and active researcher, he focuses on kidney function biomarkers, cardiovascular disease risk, and peripheral artery disease in kidney patients while also serving as an associate editor for BMC Nephrology.